SCHEDULE: FMR LLC Reduces Stake in PROCEPT BioRobotics to 2.9%

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 2.9% in PROCEPT BIOROBOTICS CORP, indicating a reduction from previous holdings.

Summary

• FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 5 to Schedule 13G for PROCEPT BIOROBOTICS CORP.
• The filing reports an aggregate beneficial ownership of 1,610,138.49 shares of common stock, representing 2.9% of the class.
• FMR LLC holds sole voting power over 1,604,986.00 shares and sole dispositive power over 1,610,138.49 shares.
• Abigail P. Johnson holds sole dispositive power over 1,610,138.49 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• FMR LLC is classified as a parent holding company or control person, with subsidiaries including Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative signal, as a significant institutional investor has reduced its stake in PROCEPT BIOROBOTICS CORP below the 5% threshold, indicating decreased conviction.

Negatives

• FMR LLC and Abigail P. Johnson have reduced their beneficial ownership in PROCEPT BIOROBOTICS CORP to 2.9%, falling below the 5% threshold that typically triggers a Schedule 13G filing, suggesting a decrease in institutional conviction.

Future Outlook

NA

Management Comments

• FMR LLC and Abigail P. Johnson certify that, to the best of their knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that a reduction in stake by a major institutional investor like FMR LLC, a prominent asset manager, can signal a shift in investment strategy or a re-evaluation of the company's prospects within the competitive medical robotics and device industry. While the 2.9% stake is still notable, falling below the 5% threshold suggests a less active or reduced conviction position compared to prior filings.

Comparison to Industry Standards

• Institutional ownership changes are closely watched indicators. A reduction in stake by a major fund like FMR LLC, which manages substantial assets, often prompts other investors to re-evaluate their positions in the company.
• While specific comparable companies or projects are not detailed in this ownership filing, the general trend of institutional investment in the medical technology sector, particularly in innovative areas like biorobotics, remains strong. However, a reduction by a key player like FMR LLC could suggest a more cautious outlook on PROCEPT BIOROBOTICS relative to its peers or the broader market.

Stakeholder Impact

• Shareholders may perceive the reduction in FMR LLC's stake as a negative signal, potentially influencing their investment decisions.
• The company's management might face increased scrutiny regarding its performance and future outlook following a major institutional investor's reduced position.

Key Dates

Recommendation

The reduction in FMR LLC's beneficial ownership below the 5% threshold suggests a decrease in institutional confidence in PROCEPT BIOROBOTICS CORP. This could signal potential headwinds or a re-evaluation of the investment by a major player, warranting a 'sell' recommendation for investors to consider reducing their exposure.

Keywords

PROCEPT BIOROBOTICS, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Medical Devices, Robotics